Kazia Therapeutics Limited. Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
Kazia Therapeutics Limited. (KZIA) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of 0 AUD/shares for the 12-month period ending 2025-06-30, per its 20-F filed 2025-11-07.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2025-11-07
AUD
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2019-06-30 | 0.00 AUD 20-F · filed 2020-10-22 |
AUD/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2025-06-30 | 0.00 AUD/shares 20-F · filed 2025-11-07 |
| 2024-06-30 | 0.00 AUD/shares 20-F · filed 2025-11-07 |
| 2023-06-30 | 0.00 AUD/shares 20-F · filed 2024-11-15 |
| 2022-06-30 | 0.67 AUD/shares 20-F · filed 2023-10-26 |
| 2021-06-30 | 0.62 AUD/shares 20-F · filed 2022-10-17 |
| 2019-06-30 | 0.00 AUD/shares 20-F · filed 2020-10-22 |